97 related articles for article (PubMed ID: 23358981)
1. Cytochrome P17 inhibition with ketoconazole as treatment for advanced granulosa cell ovarian tumor.
Garcia-Donas J; Hurtado A; García-Casado Z; Albareda J; López-Guerrero JA; Alemany I; Grande E; Camara JC; Hernando S
J Clin Oncol; 2013 Apr; 31(10):e165-6. PubMed ID: 23358981
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer.
Gil-Bazo I; Arévalo E; Castillo A; Zudaire ME; Carranza OE; Fusco JP; Castañón E; Collado-Gómez V; López I; Gil-Aldea I
Clin Genitourin Cancer; 2013 Jun; 11(2):78-84. PubMed ID: 23260990
[TBL] [Abstract][Full Text] [Related]
3. Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas J; Hurtado A; Garrigos L; Santaballa A; Redondo A; Vidal L; Lainez N; Guerra E; Rodriguez V; Cueva J; Bover I; Palacio I; Rubio MJ; Prieto M; Lopez-Guerrero JA; Rodriguez-Moreno JF; Garcia-Casado Z; Garcia-Martinez E; Taus A; de Castro IP; Navarro P; Grande E;
Clin Transl Oncol; 2023 Jul; 25(7):2090-2098. PubMed ID: 36708371
[TBL] [Abstract][Full Text] [Related]
4. Unusual virilization in girls with juvenile granulosa cell tumors of the ovary is related to intratumoral aromatase deficiency.
Kalfa N; Méduri G; Philibert P; Patte C; Boizet-Bonhoure B; Thibaut E; Pienkowski C; Jaubert F; Misrahi M; Sultan C
Horm Res Paediatr; 2010; 74(2):83-91. PubMed ID: 20395670
[TBL] [Abstract][Full Text] [Related]
5. FOXL2 mutation in granulosa-cell tumours of the ovary.
Kim T; Sung CO; Song SY; Bae DS; Choi YL
Histopathology; 2010 Feb; 56(3):408-10. PubMed ID: 20459545
[No Abstract] [Full Text] [Related]
6. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
Ohara N; Teramoto K; Murao S
J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
[No Abstract] [Full Text] [Related]
7. Adult-type granulosa cell tumors and FOXL2 mutation.
Köbel M; Gilks CB; Huntsman DG
Cancer Res; 2009 Dec; 69(24):9160-2. PubMed ID: 19996294
[TBL] [Abstract][Full Text] [Related]
8. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?
Malik ST; Slevin ML
Br J Cancer; 1991 Mar; 63(3):410-1. PubMed ID: 1825918
[No Abstract] [Full Text] [Related]
10. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.
McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB
Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170
[TBL] [Abstract][Full Text] [Related]
12. Cancer genomes on a shoestring budget.
Shendure J; Stewart CJ
N Engl J Med; 2009 Jun; 360(26):2781-3. PubMed ID: 19516026
[No Abstract] [Full Text] [Related]
13. [A case of granulosa cell tumor with unusual histologic features].
Nakayama T; Nakai Y; Tamura H; Nagano T; Shibamoto T; Ohara A; Ozawa M; Kurata A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):367-70. PubMed ID: 1904472
[No Abstract] [Full Text] [Related]
14. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
[TBL] [Abstract][Full Text] [Related]
15. Outcome of an adult granulosa cell tumour in an adolescent initially managed by laparoscopy.
Lacreuse I; Becmeur F; Marcelin L; Lutz P
Eur J Pediatr Surg; 2008 Jun; 18(3):202-4. PubMed ID: 18493900
[TBL] [Abstract][Full Text] [Related]
16. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
18. Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation.
Benayoun BA; Anttonen M; L'Hôte D; Bailly-Bechet M; Andersson N; Heikinheimo M; Veitia RA
Oncogene; 2013 May; 32(22):2739-46. PubMed ID: 22797072
[TBL] [Abstract][Full Text] [Related]
19. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
Hardy RD; Bell JG; Nicely CJ; Reid GC
Gynecol Oncol; 2005 Mar; 96(3):865-9. PubMed ID: 15721440
[TBL] [Abstract][Full Text] [Related]
20. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
